Skip to content
healthcare.dev

pioglitazone and glimepiride

NDC 66993-821, pioglitazone and glimepiride, tablet, from Prasco Laboratories.

Product NDC
66993-821
Status
Listed
Labeler
Prasco Laboratories
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA021925
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66993-821 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PIOGLITAZONE HYDROCHLORIDE30 mg/1
  • GLIMEPIRIDE2 mg/1

Pharmacologic classes

Peroxisome Proliferator Receptor alpha Agonist [EPC]; Peroxisome Proliferator Receptor gamma Agonist [EPC]; Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]; Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]; Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]; Thiazolidinedione [EPC]; Thiazolidinediones [CS]

Package NDCNDC-11Package
66993-821-306699308213030 TABLET in 1 BOTTLE (66993-821-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ea385b3d-cb4c-4550-97b0-93a86533f6dc
  • NADAC price for package 66993082130

    GET /v1/drugs/nadac/66993082130

Use it

Look up 66993-821 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66993-821 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66993-821. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.